These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17699197

  • 1. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
    Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A.
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):109-16. PubMed ID: 17699197
    [Abstract] [Full Text] [Related]

  • 2. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
    Duncan N, Dhaygude A, Owen J, Cairns TD, Griffith M, McLean AG, Palmer A, Taube D.
    Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.
    Cho ME, Hurley JK, Kopp JB.
    Am J Kidney Dis; 2007 Feb; 49(2):310-7. PubMed ID: 17261434
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial.
    Ren H, Shen P, Li X, Pan X, Zhang W, Chen N.
    Am J Nephrol; 2013 Feb; 37(1):84-90. PubMed ID: 23343906
    [Abstract] [Full Text] [Related]

  • 5. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
    Pokhariyal S, Gulati S, Prasad N, Sharma RK, Singh U, Gupta RK, Mittal S, Mehta B.
    J Nephrol; 2003 Feb; 16(5):691-6. PubMed ID: 14733415
    [Abstract] [Full Text] [Related]

  • 6. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 7. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 8. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Aug; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases.
    Tsagalis G, Psimenou E, Iliadis A, Nakopoulou L, Laggouranis A.
    Am J Kidney Dis; 2009 Aug; 54(2):340-4. PubMed ID: 19303679
    [Abstract] [Full Text] [Related]

  • 10. Use of sirolimus in patients with primary steroid-resistant nephrotic syndrome.
    Liern M, De Reyes V, Fayad A, Vallejo G.
    Nefrologia; 2012 May 14; 32(3):321-8. PubMed ID: 22508141
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 14; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 12. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
    Nowacka-Cieciura E, Perkowska-Ptasińska A, Sulikowska-Rowińska A, Cieciura T, Wazna E, Durlik M.
    Transplant Proc; 2009 May 14; 41(1):441-5. PubMed ID: 19249576
    [Abstract] [Full Text] [Related]

  • 13. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group.
    J Am Soc Nephrol; 2005 Apr 14; 16(4):1061-8. PubMed ID: 15716334
    [Abstract] [Full Text] [Related]

  • 14. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
    Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS.
    Transplantation; 2007 Aug 27; 84(4):467-74. PubMed ID: 17713429
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis.
    Cattran DC.
    Semin Nephrol; 2003 Mar 27; 23(2):234-41. PubMed ID: 12704584
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive treatment in primary focal segmental glomerulosclerosis.
    Xu S, Xu G, Zeng L.
    J Nephrol; 2012 Nov 15; 25(5):626-35. PubMed ID: 22344540
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.
    Arikan H, Koc M, Cakalagaoglu F, Eren Z, Segal MS, Tuglular S, Ozener C, Akoglu E.
    J Nephrol; 2008 Nov 15; 21(5):713-21. PubMed ID: 18949726
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec 15; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 20. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus.
    Bhimma R, Adhikari M, Asharam K, Connolly C.
    Am J Nephrol; 2006 Dec 15; 26(6):544-51. PubMed ID: 17159342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.